Circulating Tumor Cell clinical trials

Explore recruiting circulating tumor cell clinical trials.

Recruiting circulating tumor cell studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Circulating Tumor Cell trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)

Poland, Germany, France, Finland, Italy, Ireland +5 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

AMBRE : Open-label, randomized, multicenter, phase III study, comparing standard chemotherapy to standard combination of endocrine therapy with Abemaciclib as initial Metastatic treatment among patients with visceral metastasis of ER+ HER2- BREast cancer, high burden disease.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Circulating Tumor Cell trials by city

Circulating Tumor Cell clinical trials

Recruiting circulating tumor cell studies right now

Propofol vs Sevo for Paediatric Tumor Surgery

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

EUS Guided HVA and PVA for Circulating Tumor DNA in Patients

ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer

Neoadjuvant Tebentafusp for Uveal Melanoma

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Also recruiting in Europe

Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)

AMBRE : Open-label, randomized, multicenter, phase III study, comparing standard chemotherapy to standard combination of endocrine therapy with Abemaciclib as initial Metastatic treatment among patients with visceral metastasis of ER+ HER2- BREast cancer, high burden disease.

Circulating Tumor Cell trials by city

Other conditions